{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T14:57:44Z","timestamp":1774364264714,"version":"3.50.1"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,3,24]]},"DOI":"10.7759\/cureus.105765","type":"journal-article","created":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T14:05:39Z","timestamp":1774361139000},"source":"Crossref","is-referenced-by-count":0,"title":["Beyond Hypothyroid Myopathy: Signal Recognition Particle (SRP)-Negative Necrotizing Dermatomyositis Unmasked by Anti-nuclear Matrix Protein 2 (Anti-NXP2) Positivity in a 60-Year-Old Woman With Hashimoto\u2019s Thyroiditis"],"prefix":"10.7759","author":[{"given":"Jyothsna","family":"Goranti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mirella","family":"Marrufo Huanca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose Luis","family":"Diaz Macip","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gonzalo A","family":"Banchon Macias","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zeeshan","family":"Afzal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23084301","article-title":"Pathophysiological mechanisms and treatment of dermatomyositis and immune mediated necrotizing myopathies: a focused review","volume":"23","author":"Kamperman RG","year":"2022","unstructured":"Kamperman RG, van der Kooi AJ, de Visser M, Aronica E, Raaphorst J. Pathophysiological mechanisms and treatment of dermatomyositis and immune mediated necrotizing myopathies: a focused review. Int J Mol Sci. 2022, 23:4301. 10.3390\/ijms23084301","journal-title":"Int J Mol Sci"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1002\/acr.23210","article-title":"Cutaneous and systemic findings associated with nuclear matrix protein 2 antibodies in adult dermatomyositis patients","volume":"69","author":"Rogers A","year":"2017","unstructured":"Rogers A, Chung L, Li S, Casciola-Rosen L, Fiorentino DF. Cutaneous and systemic findings associated with nuclear matrix protein 2 antibodies in adult dermatomyositis patients. Arthritis Care Res (Hoboken). 2017, 69:1909-14. 10.1002\/acr.23210","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000040605","article-title":"A retrospective study for clinical characteristics of 293 patients with dermatomyositis","volume":"103","author":"Xie X","year":"2024","unstructured":"Xie X, Dai X, Liu H, Xing Y. A retrospective study for clinical characteristics of 293 patients with dermatomyositis. Medicine (Baltimore). 2024, 103:e40605. 10.1097\/MD.0000000000040605","journal-title":"Medicine (Baltimore)"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keab518","article-title":"Anti-nuclear matrix protein 2 antibody-positive inflammatory myopathies represent extensive myositis without dermatomyositis-specific rash","volume":"61","author":"Ichimura Y","year":"2022","unstructured":"Ichimura Y, Konishi R, Shobo M, et al.. Anti-nuclear matrix protein 2 antibody-positive inflammatory myopathies represent extensive myositis without dermatomyositis-specific rash. Rheumatology (Oxford). 2022, 61:1222-7. 10.1093\/rheumatology\/keab518","journal-title":"Rheumatology (Oxford)"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1002\/acr.23188","article-title":"Antinuclear matrix protein 2 autoantibodies and edema, muscle disease, and malignancy risk in dermatomyositis patients","volume":"69","author":"Albayda J","year":"2017","unstructured":"Albayda J, Pinal-Fernandez I, Huang W, et al.. Antinuclear matrix protein 2 autoantibodies and edema, muscle disease, and malignancy risk in dermatomyositis patients. Arthritis Care Res (Hoboken). 2017, 69:1771-6. 10.1002\/acr.23188","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000011501","article-title":"Anti-NXP2-antibody-positive immune-mediated necrotizing myopathy associated with acute myeloid leukemia: a case report","volume":"97","author":"Su L","year":"2018","unstructured":"Su L, Yang Y, Jia Y, Liu X, Zhang W, Yuan Y, Li Z. Anti-NXP2-antibody-positive immune-mediated necrotizing myopathy associated with acute myeloid leukemia: a case report. Medicine (Baltimore). 2018, 97:e11501. 10.1097\/MD.0000000000011501","journal-title":"Medicine (Baltimore)"},{"key":"ref7","article-title":"Hypothyroid myopathy","author":"Fariduddin MM","year":"2025","unstructured":"Fariduddin MM, Haq N, Bansal N. Hypothyroid myopathy. StatPearls [Internet]. StatPearls Publishing, Treasure Island (FL); 2025."},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2024.1361581","article-title":"Hypothyroidism and dermato\/polymyositis: a two-sample Mendelian randomization study","volume":"15","author":"Li Q","year":"2024","unstructured":"Li Q, Yang S, Ma Y, Huang H, Zhi L, Wang S, Lu L. Hypothyroidism and dermato\/polymyositis: a two-sample Mendelian randomization study. Front Endocrinol (Lausanne). 2024, 15:1361581. 10.3389\/fendo.2024.1361581","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1002\/mus.28114","article-title":"Management of immune-mediated necrotizing myopathy","volume":"70","author":"Suh J","year":"2024","unstructured":"Suh J, Amato AA. Management of immune-mediated necrotizing myopathy. Muscle Nerve. 2024, 70:166-72. 10.1002\/mus.28114","journal-title":"Muscle Nerve"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.nmd.2017.09.016","article-title":"224th ENMC International Workshop: clinico-sero-pathological classification of immune-mediated necrotizing myopathies Zandvoort, The Netherlands, 14-16 October 2016","volume":"28","author":"Allenbach Y","year":"2018","unstructured":"Allenbach Y, Mammen AL, Benveniste O, Stenzel W. 224th ENMC International Workshop: clinico-sero-pathological classification of immune-mediated necrotizing myopathies Zandvoort, The Netherlands, 14-16 October 2016. Neuromuscul Disord. 2018, 28:87-99. 10.1016\/j.nmd.2017.09.016","journal-title":"Neuromuscul Disord"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1002\/acr.22920","article-title":"Longitudinal course of disease in a large cohort of myositis patients with autoantibodies recognizing the signal recognition particle","volume":"69","author":"Pinal-Fernandez I","year":"2017","unstructured":"Pinal-Fernandez I, Parks C, Werner JL, et al.. Longitudinal course of disease in a large cohort of myositis patients with autoantibodies recognizing the signal recognition particle. Arthritis Care Res (Hoboken). 2017, 69:263-70. 10.1002\/acr.22920","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1111\/joim.12451","article-title":"Myositis-specific autoantibodies: an important tool to support diagnosis of myositis","volume":"280","author":"Betteridge Z","year":"2016","unstructured":"Betteridge Z, McHugh N. Myositis-specific autoantibodies: an important tool to support diagnosis of myositis. J Intern Med. 2016, 280:8-23. 10.1111\/joim.12451","journal-title":"J Intern Med"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)03540-6","article-title":"Frequency of specific cancer types in dermatomyositis and polymyositis: a population-based study","volume":"357","author":"Hill CL","year":"2001","unstructured":"Hill CL, Zhang Y, Sigurgeirsson B, et al.. Frequency of specific cancer types in dermatomyositis and polymyositis: a population-based study. Lancet. 2001, 357:96-100. 10.1016\/S0140-6736(00)03540-6","journal-title":"Lancet"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1402225","article-title":"Inflammatory muscle diseases","volume":"372","author":"Dalakas MC","year":"2015","unstructured":"Dalakas MC. Inflammatory muscle diseases. N Engl J Med. 2015, 372:1734-47. 10.1056\/NEJMra1402225","journal-title":"N Engl J Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/471901-beyond-hypothyroid-myopathy-signal-recognition-particle-srp-negative-necrotizing-dermatomyositis-unmasked-by-anti-nuclear-matrix-protein-2-anti-nxp2-positivity-in-a-60-year-old-woman-with-hashimotos-thyroiditis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T14:05:41Z","timestamp":1774361141000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/471901-beyond-hypothyroid-myopathy-signal-recognition-particle-srp-negative-necrotizing-dermatomyositis-unmasked-by-anti-nuclear-matrix-protein-2-anti-nxp2-positivity-in-a-60-year-old-woman-with-hashimotos-thyroiditis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,24]]},"references-count":14,"URL":"https:\/\/doi.org\/10.7759\/cureus.105765","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3,24]]}}}